HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and anti-tumor-promoting activity of glycoglycerolipid analogues lacking the glycerol backbone.

Abstract
Glycoglycerolipid analogues lacking the glycerol backbone were prepared through a lipase catalyzed transesterification of beta-D-galactosylethylene glycol. The inhibitory effect of the resultant isomeric hexanoates at the primary alcoholic positions, beta-D-galactosylethylene glycol itself and nonyl beta-D-galactopyranoside, was tested on Epstein-Barr virus early antigen (EBV-EA) activation in Raji cells promoted by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), as a primary screening test for inhibitors of tumor promotion. All the compounds assayed were found to be less active than the reference 2-O-beta-D-galactopyranosylglycerol derivatives, of which they are simplified models, indicating that the anti-tumor-promoting activity is very closely related to the presence of a free hydroxymethylene group on the glycerol-like aglycone moiety.
AuthorsDiego Colombo, Fiamma Ronchetti, Antonio Scala, Lucio Toma, Harukuni Tokuda, Hoyoku Nishino
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 11 Issue 6 Pg. 909-12 (Mar 20 2003) ISSN: 0968-0896 [Print] England
PMID12614876 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticarcinogenic Agents
  • Antigens, Viral
  • Carcinogens
  • Epstein-Barr virus early antigen
  • Glycolipids
  • glycerolglycolipids
  • Lipase
  • Tetradecanoylphorbol Acetate
  • Glycerol
Topics
  • Anticarcinogenic Agents (chemical synthesis, pharmacology)
  • Antigens, Viral (metabolism)
  • Candida (metabolism)
  • Carcinogens (antagonists & inhibitors, toxicity)
  • Drug Screening Assays, Antitumor
  • Glycerol (chemistry)
  • Glycolipids (chemical synthesis, chemistry, pharmacology)
  • Humans
  • Lipase (metabolism)
  • Pseudomonas (enzymology)
  • Tetradecanoylphorbol Acetate (antagonists & inhibitors, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: